Press Zone: Debiopharm & the PSI

Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic product in Oncology.

Press photo database

The use of these pictures is limited exclusively to the announcement of the collaboration between Debioharm International and the Paul Scherrer Institute.
Each picture must be accompanied by its complete corresponding credits and caption. No modification of photos is allowed.